Integrated clinical trial site organisation Adaptive Research has announced a partnership with AHMC Seton Medical Center for expanding clinical trial access in both in- and out-patient settings.
Founded in 1893, Seton Medical Center provides a complete range of medical specialities on inpatient, outpatient, and emergency bases, as well as surgical services.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
It has been serving the health care requirements of northern San Mateo County and San Francisco.
The organisation is recognised for cardio-vascular excellence, stroke treatment, and STEMI certification.
Additionally, it offers radiation oncology, acute psychiatry, skilled nursing, laboratory, subacute, wound care, and imaging services for the community.
AHMC Seton Coastside operates the only stand-by, 24-hour emergency department located on the Pacific Coast between Daly City and Santa Cruz.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataPharmaceutical companies and clinical research organisations (CROs) will be able to use Seton as a clinical trial site through this collaboration.
They may use Seton for conducting investigative trials if their studies align with the patient population of the organisation, as well as the interest of the people taking part.
AHMC Seton Medical Center administrator Sarkis Vartanian said: “We are excited to partner with Adaptive Research to offer clinical trials on our campus.
“At Seton, we pride ourselves on innovation when it comes to patient care and this arrangement provides another unique offering for our community.”
In March last year, Adaptive Research announced a collaboration with American Molecular Imaging to add approximately 500 specially trained radiologists to its growing research network.
American Molecular Imaging joined the Adaptive Research network to generate better access to clinical trials and provide a path to market for medical products.
